Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing

The causative agent of the ongoing pandemic in the world is SARS-CoV-2. The research on SARS-CoV-2 has progressed with lightning speed on various fronts, including clinical research and treatment, virology, epidemiology, drug development, and vaccine research. Recent studies reported that sera from...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthumani, Kar, Xu, Ziyang, Jeong, Moonsup, Maslow, Joel N., Kalyanaraman, Vaniambadi S., Srinivasan, Alagarsamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248284/
https://www.ncbi.nlm.nih.gov/pubmed/34230895
http://dx.doi.org/10.1186/s41231-021-00093-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248284/
https://www.ncbi.nlm.nih.gov/pubmed/34230895
http://dx.doi.org/10.1186/s41231-021-00093-2

Ejemplares similares